Helder Santos

Helder Santos

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2022 in Revista Portuguesa de Cardiologia
Verified
Journal Article
Open access
HSHelder Santos
Helder Santos
MSMariana Santos
Mariana Santos
SPSofia B. Paula
Sofia B. Paula
MFMargarida Figueiredo
Margarida Figueiredo
IAInês Almeida
Inês Almeida
LALurdes Almeida
Lurdes Almeida
Acute coronary syndrome (ACS) is the result of a complex pathophysiological process with various dynamic factors. The 10-item Perceived Stress Scale (PSS-10) is a validated instrument for estimating stress levels in clinical practice and may be useful in the assessment of ACS. We carried out a single-center prospective study engaging patients hospitalized with ACS between March 20, 2019 and March 3, 2020. The PSS-10 was completed during the hospitalization period. The ACS group was compared to a control group (the general Portuguese population), and a subanalysis in the stress group were then performed. A total of 171 patients with ACS were included, of whom 36.5% presented ST-elevation myocardial infarction (STEMI), 38.1% were female and the mean PSS score was 19.5±7.1. Females in the control group scored 16.6±6.3 on the PSS-10 and control males scored 13.4±6.5. The female population with ACS scored 22.8±9.8 on the PSS-10 (p<0.001). Similarly, ACS males scored a mean of 17.4±6.4 (p<0.001). Pathological stress levels were not a predictor of major adverse cardiovascular events or severity at admission. ACS patients had higher perceived stress levels compared to the control group. Perceived stress level was not associated with worse prognosis in ACS patients.

8 November 2021 in European Heart Journal - Case Reports
Verified
Journal Article
Open access
PDF file
TMT Branco Mano
T Branco Mano
HSHelder Santos
Helder Santos
SRSílvia Aguiar Rosa
Sílvia Aguiar Rosa
BTB Thomas
B Thomas
LBL Baquero
L Baquero
Background: Cardiac magnetic resonance (CMR) has a unique role in evaluating pericardial disease, permitting non-invasive tissue analysis, and haemodynamic assessment. Case summary: In Case 1 of recurrent pericarditis, CMR confirmed reactivation of inflammation with late gadolinium enhancement and native T1/T2 mapping techniques, prompting therapeutic changes. In constrictive pericarditis, CMR is the only modality capable of differentiating a subacute potentially reversible form (Case 2), from a chronic, burnt out irreversible phase characterized by constrictive physiology (Case 3). Discussion: Cardiac magnetic resonance is an effective tool to tailor individual therapy, particularly in cases of recurrent and constrictive pericarditis. Late gadolinium enhancement provides diagnostic and prognostic information, and multiparametric mapping has emerged as a promising tool with incremental diagnostic value.

4 March 2022 in Journal of Arrhythmia
Verified
Journal Article
Open access
HSHelder Santos
Helder Santos
MSMariana Santos
Mariana Santos
IAInês Almeida
Inês Almeida
SPSofia B. Paula
Sofia B. Paula
SASamuel Almeida
Samuel Almeida
PSPortuguese Registry Of Acute Coronary Syndromes
Portuguese Registry Of Acute Coronary Syndromes
Background: In a stressful situation like acute coronary syndrome (ACS), the occurrence of the first episode of atrial fibrillation is more frequent. The impact of the timing occurrence of AF new‐onset (nAF) in the setting of ACS is still debatable.Methods: Multicenter retrospective study based on the Acute Coronary Syndrome Portuguese National Registry, including 29 851 patients admitted for ACS between 1/10/2010 and 4/09/2019. The group with early nAF ‐ nAF in the first 48 h of hospitalization; and late nAF ‐ patients with nAF after the first 48 h of in‐hospital admission.Results: New‐onset AF was identified in 1067 patients, nonetheless, just 38.1% had late nAF. The group with late nAF presented more cardiovascular comorbidities and worse left ventricular ejection fraction. Late nAF patients received more anti‐arrhythmic therapy, and early nAF had a higher beta‐block prescription. Early nAF had higher rates of in‐hospital complications, on the other hand, late nAF group exhibited more mortality and readmission at one year follow‐up. Multiple logistic regression revealed that symptoms onset to the first medical contact time, admission hemoglobin <12 g/dl, right bundle branch block at admission, and diuretic therapy during the hospitalization for ACS were predictors of late nAF in ACS.Conclusions: The ACS population could be divided by the timing of nAF occurrence into the two groups with different characteristics, therapeutic approaches, and outcomes. Late nAF patients had a worse prognosis at 1 year follow‐up, however, the early nAF group had more major adverse cardiac events during the hospitalization for ACS.

1 September 2021 in Journal of Electrocardiology
Verified
Journal Article
Closed access
HSHelder Santos
Helder Santos
MSMariana Santos
Mariana Santos
IAInês Almeida
Inês Almeida
SPSofia B. Paula
Sofia B. Paula
JCJoana Chin
Joana Chin
LALurdes Almeida
Lurdes Almeida

7 December 2021 in Acta Cardiologica
Verified
Journal Article
Closed access
IAInês Almeida
Inês Almeida
JCJoana Chin
Joana Chin
HSHelder Santos
Helder Santos
MSMariana Santos
Mariana Santos
HMHugo Miranda
Hugo Miranda
SCSociedade Portuguesa de Cardiologia Centro Nacional de Colheita de Dados Em Cardiologia
Sociedade Portuguesa de Cardiologia Centro Nacional de Colheita de Dados Em Cardiologia
The main treatment for ST-elevation myocardial infarction (STEMI) is the re-establishment of the coronary flow of infarct-related arteries. However, 50% of cases present multivessel disease (MVD), negatively affecting mortality. Complete revascularization (CR) is currently advocated since it reduces major adverse cardiovascular events (MACE). Evaluation of the adopted revascularization strategy and its prognostic value in a Portuguese cohort of STEMI patients with MVD. Retrospective analysis of patients admitted with STEMI included in the Portuguese Registry of Acute Coronary Syndromes between 2010 and 2019. Patients were divided in two groups regarding revascularization strategy (complete versus incomplete) and compared. Independent predictors of a composite of all-cause mortality and rehospitalization for cardiovascular causes were assessed by multivariate logistic regression. A total of 3500 patients were included. A CR strategy was performed in 21.8% of patients, who were younger and healthier. They also presented more hemodynamically stable and had less kidney dysfunction and anaemia. Their coronary anatomy was less complex, with a higher prevalence of 2-vessel and a lower proportion of chronic occlusions. In-hospital and 1-year adverse events were less frequent between patients with CR. In hemodynamically stable STEMI patients, CR substantially reduced in-hospital and 1-year all-cause mortality and MACE.

19 October 2022 in Acta Medica Portuguesa
Verified
Journal Article
Open access
PDF file
HSHelder Santos
Helder Santos
MSMariana Santos
Mariana Santos
SPSofia B. Paula
Sofia B. Paula
IAInês Almeida
Inês Almeida
SASamuel Almeida
Samuel Almeida
OSOn Behalf Of The Portuguese Registry Of Acute Coronary Syndromes
On Behalf Of The Portuguese Registry Of Acute Coronary Syndromes
Introduction: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) led to changes in healthcare institutions and medical assistance. Non-SARS-CoV-2 related diseases were indirectly affected by the pandemic. Nonetheless, their treatment remains crucial. Cardiovascular conditions such as acute coronary syndrome (ACS) are common, and it was necessary to adjust medical assistance to these diseases during the pandemic. This study aimed to assess the national impact and healthcare system response during the first wave of the pandemic in patients admitted for ACS. Material and Methods: Multicenter retrospective study based on the Acute Coronary Syndrome Portuguese National Registry between the 1st January 2016 and the 28th February 2021. Two groups were defined: the previous year to the SARS-CoV-2 pandemic (March, April, May and June 2019) (952 patients) and the first wave of the pandemic (March, April, May and June 2020) (642 patients). Clinical course, time until reperfusion, in-hospital outcomes and follow-up at one year were compared between both periods. Results: There was a lower incidence of ACS between March and June 2020 compared with the same period in 2019, with a reduction of 32.6%. There were no statistically significant differences between the two periods regarding patient demographic characteristics (except for a higher prevalence of familiar cardi vascular history and chronic obstructive pulmonary disease in 2020 and higher prevalence of diabetes in 2019), clinical features, clinical management, in-hospital major adverse cardiac events, mortality and readmission at one-year follow-up. There was a trend towards longer delays until reperfusion, yet without statistical significance. The patients that developed ACS during the first wave of the SARS-CoV-2 pandemic were less often referred to percutaneous coronary intervention centers (p = 0.034) and were more frequently transferred to another hospital (p < 0.001). Conclusion: During the first wave of the SARS-CoV-2 pandemic there was a nationwide reduction in demand of healthcare services due to ACS events. Even though the Portuguese healthcare system was under strain and forced to divert resources and medical assistance towards the pandemic management, it was capable of responding adequately to ACS.